DPP4 and chronic myelogenous leukemia, BCR-ABL1 positive: Previous reports have shown that CD26 (HUGO nomenclature: DPP4) [51] and CD93 [34] are expressed in CML cells with repopulation potential, suggesting that these markers could be used as biomarkers for CML LSC.